Evidence map›Paper›PMID 30837450›Full record

ArticleCell death & disease2019

Correction to: RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.

Fu Xi Lei, Lei Jin, Xiao Ying Liu, Fritz Lai, Xu Guang Yan, Margaret Farrelly, Su Tang Guo, Xin Han Zhao, Xu Dong Zhang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Fu Xi LeiDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Lei JinSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Xiao Ying LiuSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Fritz LaiSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Xu Guang YanSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Margaret FarrellySchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Su Tang GuoSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia.
Xin Han ZhaoDepartment of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. zhaoxinhan@mail.xjtu.edu.cn.
Xu Dong ZhangSchool of Medicine and Public Health, The University of Newcastle, Newcastle, NSW, 2308, Australia. Xu.Zhang@newcastle.edu.au.ORCID http://orcid.org/0000-0001-9457-8003

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since publication of this paper, the authors have noticed that there were errors in Fig. 2A (the GAPDH of Mel-CV, Mel-CV.S, Mel-RMu and Mel-RMu.S), Fig. 2C (the GAPDH of Mel-CV.S and Mel-RMu.S), Fig. 3F (the GAPDH of Mel-CV.S and Mel-RMu.S), Fig. 3J(the GAPDH of Mel-RMu.S), Fig. 5C (the ERK1/2 of patient#3(post)), and Fig. 5F (the RIP1 of Mel-CV.S and Mel-RMu.S, the GAPDH of Mel-CV and Mel-RMu). As a result of the misfiling of the data during preparation of figures, incorrect images were inadvertently inserted in these figures. The correct figures are given below. The corrections do not alter the conclusions of the paper.

Identifiers

PMID30837450
PMCPMC6401075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.